Cargando…

Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt

OBJECTIVE: To explore the predictive value of model for end-stage liver disease (MELD)-Sarcopenia score for survival of cirrhotic patients after transjugular intrahepatic portosystemic shunt (TIPS) placement. METHODS: 289 patients who underwent TIPS between February 2016 and December 2020 were inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Yao-wei, Liu, Jia-cheng, Yang, Chong-tu, Wang, Ying-liang, Wang, Chao-yang, Ju, Shu-guang, Zhou, Chen, Huang, Song-jiang, Li, Tong-qiang, Chen, Yang, Yao, Wei, Xiong, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2022
Materias:	Original Articles: Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345516/ https://www.ncbi.nlm.nih.gov/pubmed/35594511 http://dx.doi.org/10.1097/MEG.0000000000002391

Ejemplares similares

Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes
por: Helzberg, James H, et al.
Publicado: (2022)

Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt
por: Yang, Chongtu, et al.
Publicado: (2021)

First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan
por: Tsuruya, Kota, et al.
Publicado: (2023)

Using transjugular intrahepatic portosystemic shunt as the first‐line therapy in secondary prophylaxis of variceal hemorrhage
por: Liu, Jiacheng, et al.
Publicado: (2019)

MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement
por: Krishnan, Arunkumar, et al.
Publicado: (2023)

Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question
por: Pitton, Michael B., et al.
Publicado: (2020)

The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage
por: Liu, Jiacheng, et al.
Publicado: (2020)

Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial
por: Qi, Xingshun, et al.
Publicado: (2013)

The impact of thrombocytopenia on variceal bleeding in cirrhotic patients with transjugular intrahepatic portosystemic shunt
por: Chen, Yang, et al.
Publicado: (2023)

The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014)

Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Luo, Xuefeng, et al.
Publicado: (2013)

Risk of hernia-related complications after transjugular intrahepatic portosystemic shunt creation in patients with pre-existing ventral abdominal hernias: 15-year experience at a quaternary medical center
por: McDaniel, Charles, et al.
Publicado: (2022)

Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury
por: Bhatia Kapoor, Puja, et al.
Publicado: (2023)

Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021)

Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt
por: Luo, Shi-Hua, et al.
Publicado: (2017)

Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)
por: de Wit, K, et al.
Publicado: (2020)

Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access
por: Cheng, Zhang, et al.
Publicado: (2019)

Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis
por: Wang, Chaoyang, et al.
Publicado: (2022)

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
por: Huang, Long, et al.
Publicado: (2015)

The Pull-Through Technique for Recanalization of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Chen, Si-liang, et al.
Publicado: (2020)

Transcaval Transjugular Intrahepatic Portosystemic Shunt: Preliminary Clinical Results
por: Lee, Kwang-Hun, et al.
Publicado: (2003)

Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS)
por: Krajina, Antonin, et al.
Publicado: (2012)

Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update
por: Rajesh, Sasidharan, et al.
Publicado: (2020)

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
por: Tripathi, Dhiraj, et al.
Publicado: (2020)

Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites in Gaucher Disease
por: Adhyaru, Kunal, et al.
Publicado: (2022)

Biliary Obstruction After Transjugular Intrahepatic Portosystemic Shunt Placement
por: Patel, Feenalie, et al.
Publicado: (2021)

Modified gun-sight transjugular intrahepatic portosystemic shunt technique
por: Lukies, Matthew, et al.
Publicado: (2022)

Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt
por: Yin, Liang, et al.
Publicado: (2023)

Evolution, progress, and prospects of research on transjugular intrahepatic portosystemic shunt applications
por: Wang, Peng, et al.
Publicado: (2021)

Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt
por: Wang, Lan-Jing, et al.
Publicado: (2023)

Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome
por: Zhao, Hongwei, et al.
Publicado: (2017)

Changes and influencing factors of liver volume after transjugular intrahepatic portosystemic shunt: a retrospective cohort study
por: Bai, Yaowei, et al.
Publicado: (2023)

Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt
por: He, Fuliang, et al.
Publicado: (2016)

Prediction of Mortality after Emergent Transjugular Intrahepatic Portosystemic Shunt Placement: Use of APACHE II, Child-Pugh and MELD Scores in Asian Patients with Refractory Variceal Hemorrhage
por: Tzeng, Wen-Sheng, et al.
Publicado: (2009)

Transient Hemolytic Anemia after Transjugular Intrahepatic Portosystemic Stent Shunt
por: Garcia-Rebollo, Sagrario, et al.
Publicado: (1996)

The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status
por: Pomier-Layrargues, Gilles, et al.
Publicado: (2012)

The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancer
por: Wong, Katherine, et al.
Publicado: (2018)

Precision Onion Skinning Technique for Transjugular Intrahepatic Portosystemic Shunt Revision
por: Matteo, Jerry, et al.
Publicado: (2018)

Stress-Induced Takotsubo Cardiomyopathy After Transjugular Intrahepatic Portosystemic Shunt
por: Lamb, Bernadette, et al.
Publicado: (2020)

Statin-Induced Rhabdomyolysis Associated With Transjugular Intrahepatic Portosystemic Shunt Placement
por: Swei, Eric C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6v6arjmptp7ok8mkn2v36h5j0g